We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WEST:NASDAQWestrock Coffee Company Analysis

Data as of 2026-09-01 - not real-time

$7.79

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Westrock Coffee Company is bullish at $7.79, with short-term averages leading the long-term ones. It has gained 6.9% over the past 30 days. Relative strength is 41.4 — neutral — and the MACD signal is bearish. The recent range runs from support at $6.52 up to resistance at $8.73.
The shares look fair at 43.3 times earnings, though no sector average was available for comparison. Sell-side targets cluster 28.4% above the current quote. Revenue is growing at 8.8% on a -4.9% profit margin.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 36.3%, a beta of 0.71 and a maximum drawdown of 32.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.

Top Market Events

Westrock Coffee Company NASDAQ:WEST reported second-quarter results on Friday that came in below Wall Street...LITTLE ROCK, Ark., Aug. 06, 2026 GLOBE NEWSWIRE -- Westrock Coffee Company Nasdaq: WEST 'Westrock Coffee” or the...LITTLE ROCK, Ark., July 20, 2026 GLOBE NEWSWIRE -- Westrock Coffee Company NASDAQ: WEST 'Westrock Coffee' or the...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 5.99
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 5.99
  • Analyst targets imply +28.4% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -4.9%
  • Analyst targets imply +28.4% versus the current price
  • Negative return on equity of -23.9%

Key Metrics & Analysis

Financial Health

Revenue Growth8.80%
Profit Margin-4.88%
P/E Ratio43.3
ROE-23.92%
ROA-0.07%
Debt/Equity277.19
P/B Ratio-37.6
Op. Cash Flow$25.0M
Free Cash Flow$36.0M

Technical Analysis

TrendBullish
RSI41.4
Support$6.52
Resistance$8.73
MA 20$8.21
MA 50$8.04
MA 200$5.99
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$0.32
Target Price$10.00
Upside/Downside28.37%
GradeFair
TypeGrowth

Risk Assessment

Beta0.71
Volatility36.31%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.